1. Piroxicam compresse sublinguali a rapida dissoluzione vs. naprossene nel trattamento dell’osteoartrosi riacutizzata [Fast-dissolving sublingual tablets of piroxicam versus naproxen in the treatment of recurrent acute osteoarthrosis. Multicenter clinical trial];Consoli;Minerva Med.,1994
2. Oral bioavailability of CHF1194, an inclusion complex of piroxicam and β-cyclodextrin, in healthy subjects under single dose and steady state conditions;Deroubaix;Eur. J. Clin. Pharmacol.,1995
3. Analgesic efficacy and the tolerance for piroxicam-beta-cyclodextrin compared to piroxicam, paracetamol and placebo in the treatment of postextraction dental pain;Dolci;Minerva Stomatol.,1993
4. Une nouvelle forme galénique: le lyoc [A new galenic form: lyoc];Jaccard;Ann. Pharm. Fr.,1985
5. Piroxicam-β-cyclodextrin a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states;Lee;Drugs,1994